Serum microRNAs in sporadic amyotrophic lateral sclerosis

Neurobiology of Aging

Volumn 36, Issue 9, 2015, Pages 2660.e15-2660.e20

  Freischmidt, Axel ^a   Müller, Kathrin ^a   Zondler, Lisa ^a   Weydt, Patrick ^a   Mayer, Benjamin ^a   von Arnim, Christine A F ^a   Hübers, Annemarie ^a   Dorst, Johannes ^a   Otto, Markus ^a   Holzmann, Karlheinz ^b   Ludolph, Albert C ^a   Danzer, Karin M ^a   Weishaupt, Jochen H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Biomarker; Diagnosis; MicroRNA; Serum

Indexed keywords

MICRORNA; MICRORNA 1234 3P; MICRORNA 1825; UNCLASSIFIED DRUG; MESSENGER RNA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIOINFORMATICS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE MUTATION; HEREDITY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RNA FINGERPRINTING; BIOLOGY; BLOOD; CLUSTER ANALYSIS; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; MUTATION;

AMYOTROPHIC LATERAL SCLEROSIS; CLUSTER ANALYSIS; COHORT STUDIES; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICROARRAY ANALYSIS; MICRORNAS; MUTATION; RNA, MESSENGER;

EID: 84940467048     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.06.003     Document Type: Article

References (30)

1. Beglopoulos V., Montag-Sallaz M., Rohlmann A., Piechotta K., Ahmad M., Montag D., Missler M. Neurexophilin 3 is highly localized in cortical and cerebellar regions and is functionally important for sensorimotor gating and motor coordination. Mol. Cell Biol. 2005, 25:7278-7288.
2. Burgos K., Malenica I., Metpally R., Courtright A., Rakela B., Beach T., Shill H., Adler C., Sabbagh M., Villa S., Tembe W., Craig D., Van Keuren-Jensen K. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One 2014, 9:e94839.
3. Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., Doykan C.E., Wu P.M., Gali R.R., Iyer L.K., Lawson R., Berry J., Krichevsky A.M., Cudkowicz M.E., Weiner H.L. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J.Clin. Invest. 2012, 122:3063-3087.
4. Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol. Brain 2013, 6:26.
5. Chekulaeva M., Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 2009, 21:452-460.
6. Cormier S., Le Bras S., Souilhol C., Vandormael-Pournin S., Durand B., Babinet C., Baldacci P., Cohen-Tannoudji M. The murine ortholog of notchless, a direct regulator of the notch pathway in Drosophila melanogaster, is essential for survival of inner cell mass cells. Mol. Cell Biol. 2006, 26:3541-3549.
7. Craig A.M., Kang Y. Neurexin-neuroligin signaling in synapse development. Curr. Opin. Neurobiol. 2007, 17:43-52.
8. De Felice B., Guida M., Guida M., Coppola C., De Mieri G., Cotrufo R. AmiRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 2012, 508:35-40.
9. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
10. Freischmidt A., Muller K., Ludolph A.C., Weishaupt J.H. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2013, 1:42.
11. Freischmidt A., Muller K., Zondler L., Weydt P., Volk A.E., Bozic A.L., Walter M., Bonin M., Mayer B., von Arnim C.A., Otto M., Dieterich C., Holzmann K., Andersen P.M., Ludolph A.C., Danzer K.M., Weishaupt J.H. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain 2014, 137(Pt 11):2938-2950.
12. Gandhi R., Healy B., Gholipour T., Egorova S., Musallam A., Hussain M.S., Nejad P., Patel B., Hei H., Khoury S., Quintana F., Kivisakk P., Chitnis T., Weiner H.L. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann. Neurol. 2013, 73:729-740.
13. Goodall E.F., Heath P.R., Bandmann O., Kirby J., Shaw P.J. Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front. Cell Neurosci. 2013, 7:178.
14. Haj-Ahmad T.A., Abdalla M.A., Haj-Ahmad Y. Potential urinary miRNA biomarker candidates for the accurate detection of prostate Cancer among benign prostatic hyperplasia patients. J.Cancer 2014, 5:182-191.
15. Hogfeldt T., Johnsson P., Grander D., Bahnassy A.A., Porwit A., Eid S., Osterborg A., Zekri A.R., Lundahl J., Khaled M.H., Mellstedt H., Moshfegh A. Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas. Leuk. Lymphoma 2014, 55:1158-1165.
16. Keller M.F., Ferrucci L., Singleton A.B., Tienari P.J., Laaksovirta H., Restagno G., Chio A., Traynor B.J., Nalls M.A. Genome-wide analysis of the heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2014, 71:1123-1134.
17. Li A., Yu J., Kim H., Wolfgang C.L., Canto M.I., Hruban R.H., Goggins M. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin. Cancer Res. 2013, 19:3600-3610.
18. Liu X.S., Chopp M., Zhang R.L., Zhang Z.G. MicroRNAs in cerebral ischemia-induced neurogenesis. J.Neuropathol. Exp. Neurol. 2013, 72:718-722.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
20. Mendell J.T., Olson E.N. MicroRNAs in stress signaling and human disease. Cell 2012, 148:1172-1187.
21. Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014, 17:17-23.
22. Ronnevi L.O., Conradi S. Increased fragility of erythrocytes from amyotrophic lateral sclerosis (ALS) patients provoked by mechanical stress. Acta Neurol. Scand. 1984, 69:20-26.
23. Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N.Engl. J. Med. 2001, 344:1688-1700.
24. Royet J., Bouwmeester T., Cohen S.M. Notchless encodes a novel WD40-repeat-containing protein that modulates Notch signaling activity. EMBO J. 1998, 17:7351-7360.
25. Toivonen J.M., Manzano R., Olivan S., Zaragoza P., Garcia-Redondo A., Osta R. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One 2014, 9:e89065.
26. van Es M.A., Dahlberg C., Birve A., Veldink J.H., van den Berg L.H., Andersen P.M. Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis. J.Neurol. Neurosurg. Psychiatry 2010, 81:562-566.
27. Viader A., Chang L.W., Fahrner T., Nagarajan R., Milbrandt J. MicroRNAs modulate Schwann cell response to nerve injury by reinforcing transcriptional silencing of dedifferentiation-related genes. J.Neurosci. 2011, 31:17358-17369.
28. Xu J., Zhao J., Evan G., Xiao C., Cheng Y., Xiao J. Circulating microRNAs: novel biomarkers for cardiovascular diseases. J.Mol. Med. (Berl) 2012, 90:865-875.
29. Zhan L., Hanson K.A., Kim S.H., Tare A., Tibbetts R.S. Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila. PLoS One 2013, 8:e57214.
30. Zhang Z., Almeida S., Lu Y., Nishimura A.L., Peng L., Sun D., Wu B., Karydas A.M., Tartaglia M.C., Fong J.C., Miller B.L., Farese R.V., Moore M.J., Shaw C.E., Gao F.B. Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations. PLoS One 2013, 8:e76055.